Literature DB >> 8563096

Varied effects of thoracic irradiation on peripheral lymphocyte subsets in lung cancer patients.

Y Nakayama1, S Makino, Y Fukuda, K Y Min, T Ikemoto, A Shimizu, N Ohsawa.   

Abstract

To investigate the influence of thoracic irradiation on immunological competence in patients with lung cancer, we examined the changes in peripheral blood lymphocyte subsets in 15 patients before and after radiation therapy by two-color flow cytometry techniques. After radiation therapy, the percentage and the absolute number of CD4+CD45RA+ cells (naive T cells) and CD56+ and/or CD16+ cells (NK cells) decreased. The percentage of CD4+human leukocyte antigen-DR(HLA-DR)+ cells (activated CD4T cells) and CD8+HLA-DR+ cells (activated CD8T cells) increased, although the absolute number did not change significantly. Naive T cells may be more selectively damaged than memory T cells by thoracic irradiation, through their recirculation behavior. The reduction of natural killer (NK) cells is disadvantageous for anti-tumor immunity. The percentage of HLA-DR positive T lymphocytes was significantly increased, and thus the possibility of HLA-DR enhancement by irradiation cannot be excluded. Therefore, thoracic irradiation has numerous varied effects on the immunological system of lung cancer patients.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8563096     DOI: 10.2169/internalmedicine.34.959

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  7 in total

Review 1.  Radiotherapy for patients with the human immunodeficiency virus: are special precautions necessary?

Authors:  Nadine Housri; Robert Yarchoan; Aradhana Kaushal
Journal:  Cancer       Date:  2010-01-15       Impact factor: 6.860

Review 2.  Assessing the interactions between radiotherapy and antitumour immunity.

Authors:  Clemens Grassberger; Susannah G Ellsworth; Moses Q Wilks; Florence K Keane; Jay S Loeffler
Journal:  Nat Rev Clin Oncol       Date:  2019-06-26       Impact factor: 66.675

3.  Immune Status and Associated Mortality After Cancer Treatment Among Individuals With HIV in the Antiretroviral Therapy Era.

Authors:  Keri L Calkins; Geetanjali Chander; Corinne E Joshu; Kala Visvanathan; Anthony T Fojo; Catherine R Lesko; Richard D Moore; Bryan Lau
Journal:  JAMA Oncol       Date:  2020-02-01       Impact factor: 31.777

Review 4.  Natural Killer Cells and Anti-Cancer Therapies: Reciprocal Effects on Immune Function and Therapeutic Response.

Authors:  Elisa C Toffoli; Abdolkarim Sheikhi; Yannick D Höppner; Pita de Kok; Mahsa Yazdanpanah-Samani; Jan Spanholtz; Henk M W Verheul; Hans J van der Vliet; Tanja D de Gruijl
Journal:  Cancers (Basel)       Date:  2021-02-09       Impact factor: 6.639

5.  Diagnostic Dilemma: Lymphocytopenia in a Patient with Thymoma - Side Effect due to Irradiation Treatment or Development of Good's Syndrome?

Authors:  Klas Raaschou-Jensen; Terese L Katzenstein; Hanne Marquart; Lars Ryder; Gedske Daugaard
Journal:  Case Rep Oncol       Date:  2010-07-16

6.  Immune responses following stereotactic body radiotherapy for stage I primary lung cancer.

Authors:  Yoshiyasu Maehata; Hiroshi Onishi; Kengo Kuriyama; Shinichi Aoki; Masayuki Araya; Ryo Saito; Licht Tominaga; Mitsuhiko Oguri; Tsutomu Araki
Journal:  Biomed Res Int       Date:  2013-11-10       Impact factor: 3.411

Review 7.  Field size effects on the risk and severity of treatment-induced lymphopenia in patients undergoing radiation therapy for solid tumors.

Authors:  Susannah G Ellsworth
Journal:  Adv Radiat Oncol       Date:  2018-10-23
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.